pioneer 4 semaglutide Change in HbA1c with oral and active comparators at end of The Importance of Patient-Reported Outcomes

Men who used a GLP-1 drug were no more likely to get an acne diagnosis than those who did not

It has also given plenty of scientific support for conditions such as nonalcoholic fatty liver disease, cardiovascular health problems and a host of different applications to neurodegenerative diseases from Alzheimer's Disease to Parkinson's

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management

Perito ER, Lustig RH, Rosenthal PJ: Prediabetes in pediatric liver transplant recipients: mechanism and risk factors

The robust performance was primarily driven by strong demand in the US, where sales rose by 38.2%, fueled by the drugs penetration into the non-metastatic castration-sensitive prostate cancer (M0 CSPC) segment and its established use in other indications, the company said